A Study of Mirabegron (YM178) in Men With Lower Urinary Tract Symptoms (LUTS) and Bladder Outlet Obstruction (BOO)
NCT00410514 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 200
Last updated 2014-04-04
Summary
This study examined the safety, tolerability, and efficacy of mirabegron (YM178) compared to placebo.
Conditions
- Lower Urinary Tract Symptoms
- Bladder Outlet Obstruction
Interventions
- DRUG
-
Mirabegron
oral
- DRUG
-
oral
Sponsors & Collaborators
-
Astellas Pharma Inc
lead INDUSTRY
Principal Investigators
-
Use Central Contact · Astellas Pharma US, Inc.
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 45 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-12-31
- Primary Completion
- 2008-08-31
- Completion
- 2008-08-31
Countries
- United States
- Canada
Study Locations
More Related Trials
-
MIrabegron With oveRACtive bLadder Symptoms in mEn
NCT02361502 ·Status: UNKNOWN ·Phase: PHASE4
-
A Long-term Study of YM178 in Symptomatic Overactive Bladder Patients
NCT00840645 ·Status: COMPLETED ·Phase: PHASE3
-
A Prospective, Observational, Multicenter Study of Patients Following Initiation of a New Course of Treatment for Overactive Bladder (OAB)
NCT02386072 ·Status: COMPLETED
-
A Study to Evaluate Tolerability and Participants Preference Between Mirabegron and Tolterodine Extended Release (ER) in Participants With Overactive Bladder (OAB)
NCT02138747 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of YM178 in Patients With Symptomatic Overactive Bladder
NCT00527033 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate Mirabegron in Pediatric Participants From 5 to Less Than 18 Years of Age With Overactive Bladder (OAB)
NCT04641975 ·Status: TERMINATED ·Phase: PHASE3
-
Urodynamic and Clinical Efficacy of Mirabegron for Neurogenic Bladder Patients
NCT02044510 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
A Study to Evaluate the Effect of Mirabegron + Solifenacin in Overactive Bladder Patients
NCT01745094 ·Status: COMPLETED ·Phase: PHASE4
-
Add-on Mirabegron in Pediatric Patients With Refractory Overactive Bladder
NCT02476175 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of YM178 in Subjects With Symptoms of Overactive Bladder
NCT01043666 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Efficacy and Safety of Mirabegron Compared to Solifenacin in Patients With Overactive Bladder Who Were Previously Treated With Another Medicine But Were Not Satisfied With That Treatment.
NCT01638000 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Test the Efficacy and Safety of YM178 in Subjects With Symptoms of Overactive Bladder
NCT01604928 ·Status: COMPLETED ·Phase: PHASE2
-
A Multinational Study Comparing the Long-term Efficacy and Safety of Two Medicines, Solifenacin Succinate and Mirabegron Taken Together, or Separately, in Subjects With Symptoms of Overactive Bladder
NCT02045862 ·Status: COMPLETED ·Phase: PHASE3
-
A Prospective Non-interventional Study in Overactive Bladder (OAB) Patients Prescribed Betmiga® as Part of Routine Clinical Practice
NCT02320773 ·Status: COMPLETED
-
Study to Evaluate the Efficacy, Safety and Tolerability of Vibegron in Men With Overactive Bladder (OAB) Symptoms on Pharmacological Therapy for Benign Prostatic Hyperplasia (BPH)
NCT03902080 ·Status: COMPLETED ·Phase: PHASE3
-
Study The Effects Of Different Doses Of UK-369,003 In Men With Overactive Bladder
NCT00479505 ·Status: COMPLETED ·Phase: PHASE2
-
Mirabegron Treatment on Patients With Overactive Bladder Syndrome in Taiwan
NCT03059134 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of MK0594 to Treat Overactive Bladder (0594-003)
NCT00290563 ·Status: COMPLETED ·Phase: PHASE2
-
Myrbetriq™ (Mirabegron) to Improve Disordered Sleep in Subjects With Lower Urinary Tract Symptoms (LUTS)
NCT02410135 ·Status: COMPLETED
-
A Study to Evaluate Safety and Efficacy of YM178 in Patients With Overactive Bladder
NCT00966004 ·Status: COMPLETED ·Phase: PHASE3
-
A Study With Mirabegron 50 mg and 25 mg in Chinese Participants With Overactive Bladder
NCT04562090 ·Status: COMPLETED ·Phase: PHASE4
-
To Evaluate the Blood and Urine Concentration and the Safety and Tolerability of Increasing Repeated Doses of Mirabegron (YM178) OCAS in Healthy Young and Elderly Males and Healthy Young and Elderly Females
NCT01478503 ·Status: COMPLETED ·Phase: PHASE1
-
Fesoterodine "add-on" Male Overactive Bladder Study
NCT00546637 ·Status: COMPLETED ·Phase: PHASE3
-
Tamsulosin Phase III Clinical Trial -Double-Blind, Placebo Controlled Study in Male Patients With Lower Urinary Tract Syndrome
NCT00239317 ·Status: COMPLETED ·Phase: PHASE3
-
This Was a Multinational Study Comparing the Efficacy and Safety of Two Medicines , Solifenacin Succinate and Mirabegron Taken Together, or Separately, or a Mock Treatment (Placebo) in Subjects With Symptoms of Overactive Bladder
NCT01972841 ·Status: COMPLETED ·Phase: PHASE3